Trials / Completed
CompletedNCT05499871
Effect of a Gait Retraining Intervention and a Minimalist Footwear Transition on Foot-ankle Strength, Running Economy and Injury in Endurance Runners.
Comparison Between Gait Retraining Intervention With a Transitioning Toward Minimalist Footwear on the Foot-ankle Strength, Running Economy and Injury Incidence in Endurance Runners: a One-year Follow up Study.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 140 (actual)
- Sponsor
- University of Liege · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The main aim is to determine whether a gait retraining intervention will improve the strength of the foot-ankle muscle, the running economy and reduce the injury incidence in a one-year follow-up study. The secondary aim is to seek whether a minimal foot-ankle strength is necessary to reduce the risk to sustain to a running-related-injury to transit toward a forefoot strike pattern or toward a minimalist footwear for an endurance runner. Participants will be assessed at baseline, at 2 month follow-up, at 6 month follow-up and at 12 month follow-up. Assessment will be composed by questionnaires, a foot screening, maximal voluntary isometric strength of foot-ankle muscle with hand held dynamometer. Then, participants will run on a treadmill at self-paced and at 10 km/h with to measure their running economy and their footstrike pattern. In function of their distribution, participants will receive either nothing (control group) or minimalist footwear or a training to modify their footstrike pattern toward a more forefoot strike.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Gait retraining intervention | Participants will receive a training to modify their footstrike pattern toward a more forefoot strike and increase their cadence by 7.5%. |
| DEVICE | Transition to minimalist footwear. | Participants will receive a running minimalist footwear. |
Timeline
- Start date
- 2022-09-01
- Primary completion
- 2022-09-12
- Completion
- 2024-09-30
- First posted
- 2022-08-12
- Last updated
- 2025-05-16
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT05499871. Inclusion in this directory is not an endorsement.